Connection
Mark Lovell to Reference Values
This is a "connection" page, showing publications Mark Lovell has written about Reference Values.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.119 |
|
|
|
-
Lovell MA, Xie C, Gabbita SP, Markesbery WR. Decreased thioredoxin and increased thioredoxin reductase levels in Alzheimer's disease brain. Free Radic Biol Med. 2000 Feb 01; 28(3):418-27.
Score: 0.036
-
Reddy CC, Collins M, Lovell M, Kontos AP. Efficacy of amantadine treatment on symptoms and neurocognitive performance among adolescents following sports-related concussion. J Head Trauma Rehabil. 2013 Jul-Aug; 28(4):260-5.
Score: 0.023
-
Lovell MA, Ehmann WD, Markesbery WR. Laser microprobe analysis of brain aluminum in Alzheimer's disease. Ann Neurol. 1993 Jan; 33(1):36-42.
Score: 0.022
-
El Kasmi KC, Anderson AL, Devereaux MW, Fillon SA, Harris JK, Lovell MA, Finegold MJ, Sokol RJ. Toll-like receptor 4-dependent Kupffer cell activation and liver injury in a novel mouse model of parenteral nutrition and intestinal injury. Hepatology. 2012 May; 55(5):1518-28.
Score: 0.021
-
Gabbita SP, Aksenov MY, Lovell MA, Markesbery WR. Decrease in peptide methionine sulfoxide reductase in Alzheimer's disease brain. J Neurochem. 1999 Oct; 73(4):1660-6.
Score: 0.009
-
Gabbita SP, Lovell MA, Markesbery WR. Increased nuclear DNA oxidation in the brain in Alzheimer's disease. J Neurochem. 1998 Nov; 71(5):2034-40.
Score: 0.008